| Tretinoin | Approved Investigational Nutraceutical | CCNDBP1 | 23582 |
upregulated | Tretinoin results in increased expression of CCNDBP1 mRNA | 15q15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNE1 | 898 |
downregulated | Tretinoin results in decreased expression of CCNE1 mRNA | 19q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNE2 | 9134 |
downregulated | Tretinoin results in decreased expression of CCNE2 mRNA | 8q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNF | 899 |
downregulated | Tretinoin results in decreased expression of CCNF mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNG1 | 900 |
downregulated | Tretinoin results in decreased expression of CCNG1 mRNA | 5q34 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNO | 10309 |
upregulated | Tretinoin results in increased expression of CCNO mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNT1 | 904 |
upregulated | Tretinoin results in increased expression of CCNT1 mRNA | 12q13.11-q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNYL1 | 151195 |
downregulated | Tretinoin results in decreased expression of CCNYL1 mRNA | 2q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCPG1 | 9236 |
upregulated | Tretinoin results in increased expression of CCPG1 mRNA | 15q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCR1 | 1230 |
upregulated | Tretinoin results in increased expression of CCR1 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CCR2 | 729230 |
upregulated | Tretinoin results in increased expression of CCR2 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CCR3 | 1232 |
upregulated | Tretinoin results in increased expression of CCR3 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CCSER1 | 401145 |
upregulated | Tretinoin results in increased expression of CCSER1 mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CD14 | 929 |
upregulated | Tretinoin results in increased expression of CD14 mRNA | 5q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CD164 | 8763 |
upregulated | Tretinoin results in increased expression of CD164 mRNA | 6q21 | |
| Tretinoin | Approved Investigational Nutraceutical | CD1D | 912 |
upregulated | Tretinoin results in increased expression of CD1D mRNA | 1q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CD200 | 4345 |
downregulated | Tretinoin results in decreased expression of CD200 mRNA | 3q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CD22 | 933 |
upregulated | Tretinoin results in increased expression of CD22 mRNA | 19q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CD247 | 919 |
downregulated | Tretinoin results in decreased expression of CD247 mRNA | 1q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CD248 | 57124 |
upregulated | Tretinoin results in increased expression of CD248 mRNA | 11q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CD300A | 11314 |
upregulated | Tretinoin results in increased expression of CD300A mRNA | 17q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CD300C | 10871 |
upregulated | Tretinoin results in increased expression of CD300C mRNA | 17q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CD38 | 952 |
upregulated | Tretinoin results in increased expression of CD38 mRNA | 4p15.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CD3G | 917 |
upregulated | Tretinoin results in increased expression of CD3G mRNA | 11q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CD44 | 960 |
downregulated | Tretinoin results in decreased expression of CD44 mRNA | 11p13 | |